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1  |  INTRODUC TION
One of the major issues in newborn calves is diarrhoea. Neonatal di-
arrhoea can have several infectious causes such as Cryptosporidium 
parvum, E. coli, Salmonella, rotavirus and coronavirus, or combina-
tions of two or more pathogens (Holland, 1990; Lorenz et al., 2011; 
McGuirk, 2008; Muktar et al., 2015). Newborn calves are more sus-
ceptible to such infections as they have a naïve immune system and 
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The aim of this study was to assess the effects of feeding immunized egg proteins (IEP) 
on the health and performance of newborn dairy calves. Sixty-four Holstein calves, both 
male and female, were divided over two treatments. Calves either received IEP or a pla-
cebo (PCB) in their colostrum and calf milk replacer (CMR) for the first 14 days of their 
life. Until day 49, CMR was offered at 15% of birth weight (BW), at 10% on days 49–57 
and at 5% on days 57–63. In addition, calves received starter concentrate, chopped 
straw and water from 3 days old until 70 days old at the end of study. Individual CMR 
and concentrate intake were measured daily whilst BW was recorded weekly. Visual fae-
cal scoring and health observations were conducted daily. Faecal samples were collected 
weekly up to 4 weeks and during the first 4 days of scouring to screen for presence of 
Cryptosporidium parvum, rotavirus, coronavirus, E. coli and Salmonella. Results indicated 
that feeding IEP increased BW (p < .05) at 42 and 56 days old, and BW also tended 
(p = .06) to be higher after weaning at 63–70 days old compared to the PCB group. When 
analysed using a repeated measures model, compared to feeding PCB, feeding IEP in-
creased total concentrate consumption (p = .001) by 3.6kg/calf. Over the entire study, 
daily water intake was higher (p = .002) for the IEP group when compared with the PCB 
group. In the IEP group, 12 calves were scored as scouring whereas there were 14 calves 
in the PCB group. There were no significant differences between treatments in faecal 
pathogen load of neither healthy nor scouring calves. In conclusion, supplementing IEP 
during the first 14 days of calf life improved the performance of newborn calves. Further 
work is warranted to understand the mode of action of IEP in calves.
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are not yet able to react to specific antigens. In nature, this is overcome 
via passive immunity, in which immunoglobulins (Ig), mainly IgG, are 
transferred via the colostrum to the animals. In commercial practice, 
calves are provided colostrum during the first days of life. However, as 
neonatal diarrhoea occurs mainly during the first month of life, it could 
be considered that feeding immunoglobulin-rich colostrum during the 
first days of life does not protect sufficiently against neonatal diar-
rhoea. The immunoglobulins in the colostrum do not provide protec-
tion for long enough considering the underdeveloped immune system 
of the neonatal calf. The gap between the colostrum provision and the 
full development of the immune system should be overcome.
The principle of passive immunity in young animals is not only used 
by cattle, but also for other species such as chickens (Rose et al., 1974). 
Chickens transfer immunoglobulins, mainly IgY, via the egg yolk 
where it can be used by the chick. In the 1970s, the presence of IgA 
and IgM was confirmed in the egg white (Rose et al., 1974; Yakamoto 
et al., 1975). The IgY in the egg yolk contains the avian equivalent of 
mammalian IgG (Chalghoumi et al., 2009). Immunization of the hen re-
sults in production of specific IgY which is transferred to the egg (Lösch 
et al., 1986). Specific IgY can be obtained against bacteria, viruses and 
also parasites (Gottstein & Hemmeler, 1985). Amongst others, specific 
antibodies against Cryptosporidium parvum can be produced in the egg. 
Feeding these egg antibodies resulted in a decreased C. parvum load 
in mice, providing evidence that egg antibodies have the potential to 
reduce infection load (Cama & Sterling, 1991).
In the current study, freeze-dried whole egg, including yolk and 
egg whites, were fed to newborn calves during the first 14 days of 
life. The egg products originated from hens hyperimmunized against 
the most common pathogens causing neonatal diarrhoea in calves: 
Cryptosporidium parvum, E. coli (K88, K99, 987P and F41P), Clostridium 
perfringens (types A, C and D), Rotavirus, Coronavirus and Campylobacter 
fetus-jejuni. The objective of this study was to evaluate the effect of 
these egg products on the health and growth performance of newborn 
dairy calves. It was anticipated that these egg products would help the 
calves to overcome neonatal diarrhoea resulting in healthier calves that 
would outperform calves that did not receive the egg products.
2  |  MATERIAL AND METHODS
2.1  |  Animals
The study was conducted at the Agri-Food and Biosciences Institute 
(AFBI), Hillsborough, Northern Ireland (latitude 54°27’N; longi-
tude 06°04’W). All experimental procedures in this study were 
conducted under experimental license granted by the Department 
of Health, Social Services & Public Safety for Northern Ireland 
(DHSSPSNI) in accordance with the Animals (Scientific Procedures) 
Act 1986. A total of 64 Holstein calves (32 males, 32 females), born 
between 12 January and 6 March 2017 with average birth weight of 
40 kg (± 4.5 kg), were sourced from the AFBI dairy herd. All calves 
remained with their dam for a maximum of 13 hr after birth before 
being moved to straw bedded individual housing with an average air 
temperature of 13.5ºC (−0.4ºC to + 24.7ºC) and relative humidity of 
67% rH (31.1 to 98.1%rH).
2.2  |  Diet treatments
All animals received colostrum for the first 3 days of life after which 
colostrum was replaced with calf milk replacer (CMR). The CMR 
provided was a commercial product (Milkivit Premium Plus, with-
out Pulmo+, Trouw Nutrition) with the composition as presented in 
Table 1. The CMR (150 g/L) was provided at a rate of 15% of birth 
weight (BW) until day 49, which was reduced to 10% of BW between 
days 49 and 57, and 5% between days 57 and 63 and the calves were 
weaned at day 63. The calves remained on study until 70 days of age. 
Along with the CMR, calves had ad libitum access to concentrates 
TA B L E  1  Composition of the calf milk replacer on dry matter 
basis used during the study
Nutrient Content
Total Milk Solids, % 70
Fat (measured as ether extract), % 17
Crude protein, % 23
Crude fibre, % 0.05
Ash, % 8
Gross Energy content, MJ/kg 20.3
Vitamin A, iu/kg 50,000
Vitamin D3, iu/kg 6,000
Vitamin E, mg/kg 500
Selenium, mg/kg 0.36
Copper, mg/kg 13















Gross energy (MJ/kg) 18.1
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(Table 2), chopped straw and fresh drinking water throughout the 
experimental period. The first 23 calves enrolled in the study were 
allocated 15% BW milk allowance and were not enrolled on a buildup 
strategy of the milk replacer; however, all remaining calves were as-
signed to a milk replacer buildup scheme from 10% BW increasing to 
15% BW by 14 days of age.
Calves were balanced across treatment groups for birth weight 
and sex. Treatments consisted of a gut health additive containing 
immunized egg proteins (IEP) originating from hens vaccinated 
against Cryptosporidium parvum, Rotavirus (group A and group C), 
Coronavirus, E. coli (K88, K99, 987P and F41P), Clostridium perfrin-
gens (type A, type C and type D) and Campylobacter fetus-jejuni 
(Trycop, Trouw Nutrition, The Netherlands) or a placebo supple-
ment (PCB) containing dextrose and whey powder to correct for 
energy and protein (prepared and provided by Trouw Nutrition, 
The Netherlands), both of which were administered for the first 
14 days of life. The IEP group consisted of 17 females and 15 males, 
whereas in the PCB group, 15 females and 17 males were included. 
The calves received one feeding of colostrum containing 30 g of 
the treatment product. Thereafter, 10 g of treatment product was 
added to each colostrum or CMR feeding, resulting in 20 g per day 
over the two daily feedings. No additives were included within the 
CMR feed after day 14.
2.3  |  Performance measurements
Live weights were recorded weekly according to individual calf age 
between 7 and 70 days of age. Weighing occurred between 2 and 
4 hr post morning milk feed and was conducted using a calibrated 
mobile weighbridge (Tru-Test Eziweigh 5, Auckland, New Zealand). 
The live weights were used to calculate the average daily gain (ADG). 
Individual daily CMR and concentrate intake were recorded on a 
daily basis, and drinking water intake was recorded 5 days/week 
throughout the experimental period. The general health of all calves 
was monitored daily, and any issues identified were treated accord-
ing to standard operating procedures.
2.4  |  Faecal scoring and sampling
During the first 28 days of life, faecal consistency was visually 
assessed on a daily basis using a 4 point scoring system whereby 
1 = normal consistency, 2 = slightly liquid consistency, 3 = mod-
erately liquid consistency and 4 = primarily liquid consistency 
(Quigley et al., 2006). A calf was recorded as scouring at a score 
of 3 or 4. Faecal scoring was carried out by a trained technician. 
Scouring calves were treated by supplementing electrolytes 
(Diakur, Boehringer Ingelheim International GmbH, Ingelheim am 
Rhein, Germany) into the milk feed for 3 days. Calves that showed 
more severe scouring were treated with electrolytes in the water, 
as two additional daily feeds and a 3-day course of antibiotics. 
Rectal faecal samples were collected weekly, on days 1, 7, 14, 21 
and 28, for pathogen determination. Where scouring occurred 
within the first 28 days of life, additional faecal samples were col-
lected during the first 4 d of scouring. Faecal samples were stored 
at 4°C prior to analysis. All faecal material collected was split into 
two separate aliquots. A minimum of 10g of fresh faeces was oven 
dried at 85ºC for 48 hr for determination of dry matter content. 
The second aliquot of faeces was submitted to the laboratory for 
analysis of pathogen levels.
2.5  |  Pathogen analysis
Pathogen analysis of the faeces was conducted weekly and included 
up to 20g faecal material tested for bacterial (E.coli, Salmonella), viral 
(Rotavirus, Coronavirus) and Cryptosporidium counts. Bacteriology 
analysis was carried out according to ISO 16649–2 for Escheria coli 
0,157:H7 and ISO 16,579 for Salmonella detection. Virology anal-
ysis included the nucleic acid detection of Bovine Rotavirus and 
Coronavirus via Reverse transcription polymerase chain reaction 
(RT-PCR) on the AB 7,500 Taqman system (Thermo Fisher Scientific). 
Presence of Cryptosporidum parvum in the faecal samples was ana-
lysed using immunofluorescent antibody test (IFAT) followed by mi-
croscopy assessment to count oocysts per gram (OPG).
2.6  |  Statistical analysis
All data were tested for normality and analysed using GenStat 
16.2 (VSN International) for PC/Windows 7. All statistical mod-
els included birth weight (to account for initial variation), sex and 
CMR buildup strategy as covariates along with the fixed effects 
of time, CMR treatment and associated interactions unless other-
wise stated. Housing block was included as a random term across 
all models. Time was included as repeated measure for the growth 
performance and feed intake results. Significance was determined 
via REML analysis with variance components incorporated using a 
linear mixed model. Following repeated measures analysis of calf 
performance measures, differences between treatments at specific 
time points were detected via pairwise t test. Probability of p < .05 
was selected as the level of significance. Data were then subjected 
to Fisher's unprotected least significant difference (PLSD) test. 
Daily intakes, total intake, body weight, average daily weight gain, 
faecal score, faecal dry matter and pathogen load data were in-
cluded in the analysis.
3  |  RESULTS
3.1  |  Performance
The growth performance of calves is presented in Table 3. Body 
weight was significantly higher at d 42 (p = .03) and d 56 (p = .02), 
and tended to be higher at d 28 (p = .06), d 49 (p = .05) and d 63 
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(p = .06) in IEP calves when compared with PCB calves. At the end 
of the study on d70, IEP calves were, on average, 4 kg heavier than 
the PCB calves (p = .06). There were no significant differences in 
ADG between treatment groups, with IEP and PCB calves achiev-
ing 0.67 kg/day and 0.63 kg/day, respectively, between birth and 
70 days of age. Taking into account the slight, but non-significant, 
difference in birth weight at the start of the study, repeated meas-
ures analysis indicated growth performance was not significantly 
(live weight d 70: p = .614, ADG d0 to d70: p = .485) different be-
tween the treatments. Average daily CMR, concentrate and water 
intake are presented in Figures 1, 2 and 3, respectively. Milk replacer 
was fed as a percentage of body weight; however, a milk buildup 
scheme was subsequently introduced to permit calves to consume 
the required volume. The first 23 calves enrolled in the study were 
allocated 15% BW milk allowance and were not enrolled on a buildup 
strategy of the milk replacer; however, all remaining calves were as-
signed to a milk replacer buildup scheme from 10% BW increasing 
to 15% BW by 14 days of age. There was no significant difference 
between treatments in total CMR intake (Table 4; p = .804), includ-
ing a correction of the CMR buildup strategy. Calves supplemented 
with IEP consumed 3.6kg DM more than PCB calves between d3 and 
d70 (Table 4; p = .025). Average daily water consumption was signifi-
cantly (p < .001) greater for IEP calves during the study (Figure 3), 
who consumed approximately 14.6L more than PCB calves during 
the entire study. However, the total amount of water consumed was 
variable; therefore, the overall treatment difference was not consid-
ered significant (p = .123) unless analysed with a repeated measures 
analysis (p = .002) (Table 4).
3.2  |  Faecal scores and faecal consistency
In total 12 calves in the IEP group and 14 calves in the PCB group were 
recorded as having experienced scour. All scouring occurred within 
the first 3 weeks of life. Additionally, the dry matter content of the fae-
cal samples from the IEP group was 18.5%, whereas this was 17.8% in 
Age, Days
Body weight, kg Average Daily Gain (ADG)a , kg/day
IEP PCB SE p-value IEP PCB SE p-value
Birth 41.3 39.6 0.73 0.085
7 44.2 42.8 0.80 0.22 0.41 0.46 0.06 0.51
14 44.8 42.9 0.83 0.13 0.25 0.24 0.04 0.90
21 48.3 46.2 0.95 0.09 0.33 0.31 0.03 0.64
28 52.1 49.5 0.94 0.06 0.38 0.36 0.02 0.38
35 56.7 54.8 1.00 0.14 0.44 0.43 0.02 0.81
42 62.2 59.1 1.09 0.03 0.50 0.47 0.02 0.15
49 66.9 64.0 1.14 0.05 0.52 0.50 0.02 0.25
56 73.6 69.5 1.34 0.02 0.58 0.53 0.02 0.08
63 80.2 76.5 1.42 0.06 0.62 0.59 0.02 0.24
70 87.9 83.9 1.48 0.06 0.67 0.63 0.02 0.23
Abbreviations: IEP, immunized egg protein treatment group; PCB, placebo treatment group; SE, 
standard error.
aAverage daily gain between birth and days of age. 
TA B L E  3  The body weight and average 
daily gain per calf measured weekly 
throughout the experimental period
F I G U R E  1  The average daily milk 
replacer intake per calf for each day until 
weaning. Dotted line represents the 
immunized egg protein (IEP) group, and 
the solid line represents the placebo (PCB) 
group
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the PCB group (p = .502). However, due to the large variations among 
the calves (3.8%–52.4%), this difference was not significant.
3.3  |  Pathogenic load
Results from faecal samples submitted for microbiological analyses 
are presented in Table 5. Although not significant, in the IEP group 
numerically slightly more calves (27.5%) excreted Cryptosporidium 
parvum compared to the PCB group (22.5%). Virology results show 
that Rotavirus was observed in most calves and was excreted by nu-
merically more calves in the IEP group (70.6%) compared to the PCB 
group (65.6%). Coronavirus was the only pathogen that was excreted 
by numerically less calves in the IEP group (5.0%) compared to the 
PCB group (6.9%). Bacteriological results show that there was no 
Salmonella present in any of the calves. E. coli was excreted by 56.9% 
of the calves in the IEP group and by 55.0% calves in the PCB group. 
None of the results regarding pathogenic load were significantly dif-
ferent. From all calves that were identified as experiencing scour, 12 
in the IEP group and 14 in the PCB group, additional faecal samples 
were taken during the first 4 d of scouring. In the scouring calves, 
similar trends compared to the total population were observed. Also 
in the scouring group of calves, there were no significant differences 
observed in excretion of any pathogen.
4  |  DISCUSSION
The aim of this study was to examine the effect of immunized egg 
proteins on neonatal diarrhoea and performance of newborn calves. 
At the point of weaning, body weight was 4kg higher in calves sup-
plemented with IEP in the first 14 days of life than those calves 
provided with PCB. As a result, the ADG seemed higher for the IEP 
group although not significant, which may be related to the differ-
ences in initial body weight. As calves were allocated to the study 
as they were born, there was variation of body weight between 
treatments; however, this was accounted for within the analysis of 
growth performance data by using birth weight as a covariate in the 
statistical model. The mechanisms behind the improved body weight 
in the IEP group remain unclear from the current study, because the 
F I G U R E  2  The average daily 
concentrate intake per calf per day during 
the entire study. Dotted line represents 
the immunized egg protein (IEP) group, 
and the solid line represents the placebo 
(PCB) group
F I G U R E  3  The average daily water 
intake per calf per day during the entire 
study. Dotted line represents the 
immunized egg protein (IEP) group, and 
the solid line represents the placebo (PCB) 
group
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hypothesized effect of IEP on pathogen and scouring could not be 
confirmed. This study showed no significant impact on the presence 
of the focus pathogens, such as Cryptosporidium parvum, Rotavirus, 
Coronavirus or E. coli, nor did the scouring incidence.
Previous work by Ikemori et al. (1992) showed a lower mor-
tality in newborn calves that were fed egg antibodies against E. 
coli compared to calves fed the control diet, suggesting that there 
could be a positive impact of providing egg antibodies to neonatal 
calves. As reported by Diraviyam et al. (2014), eggs from hyper-
immunized hens contain specific antibodies (IgY) against specific 
pathogens to which the hens were vaccinated, the use of which has 
been described for calves, poultry and swine. The meta-analysis 
indicated a consistent positive effect of the IgY on diarrhoea and 
mortality by diarrhoea in poultry, swine, mice and calves. Although 
the individual studies included in the meta-analysis did not always 
show significant benefits, an overall positive effect of IgY was ob-
served, particularly with regard to its use in calves. The results of 
the current study are similar, as although diarrhoea occurrence was 
not significantly reduced in IEP calves, numerically fewer calves ex-
perienced diarrhoea.
In vitro results show that egg proteins were able to prevent 
adhesion of E. coli to the intestines by acting on the fimbriae 
(Yokoyama et al., 1992) and even cause inhibition of disease 
through direct binding of bacteria (Marcq, Thewis, Portebelle & 
Beckers, 2010). This suggests a direct mode of action of IgY in the 
intestines rather than a required uptake of the IgY into the blood-
stream, which was confirmed by Quezada-Tristán et al. (2014). 
However, in the present study immunoglobulin level in the blood 
was not determined. Additionally, the microbiology results could 
not confirm this, with no difference in pathogen/bacterial excre-
tion observed. Similarly, IgY specifically against bovine rotavirus 
resulted in some growth benefits and a delated start and shorter 
duration of diarrhoea responses were observed in rotavirus 




IEP PCB Treatment Treatment × Day
CMR (kgDM) 48.5 47.9 0.17 0.804 <0.001
Concentrate (kgDM) 34.5 30.9 0.64 0.025 0.001
CMR + concentrate 
(kgDM)
83.0 78.9 0.65 0.034 <0.001
Total drinking water 
(L)
80.3 65.7 2.52 0.123 0.002
Abbreviations: CMR, calf milk replacer; IEP, immunized egg protein treatment group; PCB, placebo 
treatment group; SE, standard error.
TA B L E  4  Cumulative feed intake 
throughout the experimental period (d 
3–63)
TA B L E  5  The number of calves in which the pathogen was detected above cut-off level. The numbers in brackets are the scouring calves 
in which the pathogen was detected above cut-off level
Parasitology Virology Bacteriology
C. parvum Rotavirus Coronavirus Salmonella E. coli
Positive cut-off level
>1,000 OPG >0 Ct RNA >0 Ct RNA Qualitative
1 × 107 
CFU/ga Age, days
Immunized egg protein 
(n = 32)
1 1 (1) 7 (3) 1 (1) 0 28
7 9 (6) 27 (12) 1 (1) 0 21
14 23 (10) 30 (11) 2 (1) 0 18
21 3 (2) 26 (12) 1 (1) 0 8
28 8 (2) 23 (9) 3 (2) 0 16
Total %b  27.5 70.6 5.0 0 56.9
Placebo (n = 32) 1 5 (2) 5 (4) 0 0 27
7 5 (3) 28 (13) 0 0 23
14 17 (8) 24 (12) 7 (4) 0 17
21 4 (0) 27 (12) 0 0 12
28 5 (3) 21 (11) 4 (1) 0 9
Total %b  22.5 65.6 6.9 0 55.0
aDetermined from mean level detected. 
bTotal %=percentage positive of all samples taken. 
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rotavirus was not decreased in the animals receiving dietary spe-
cific IgY leading the authors to conclude that IgY from vaccinated 
hens seemed to prime the neonatal mucosal immune response to 
bovine rotavirus. Although a less severe or delayed diarrhoea was 
not observed in the current study, the numerically lower frequency 
of diarrhoea occurrence in IEP calves could be suggestive of a sub-
clinical effect of the egg proteins.
If the pathogens cannot adhere to the intestine, they will be 
excreted without causing problems meaning that excretion will be 
the same regardless of IgY supplementation (Xu et al., 2011). The 
difference would be in the viability of the pathogens. The type of 
microbiological measurements used in the current study for faecal 
pathogen load did not discriminate on microbial viability.
The pathogen load analysis showed that different pathogens 
were present under the current, non-challenged, circumstances. 
This is in line with work by Holland (1990) who described that most 
infections have multiple causes. Also, the type of infections change 
in the course of life, where in the first 5 days of a calves life mostly E. 
coli can be expected, between 5 and 14 days of age infections with 
rotavirus, coronavirus, Salmonella and Cryptosporidium parvum can 
be expected (Lorenz et al., 2011; McGuirk, 2008). For these reasons, 
IgY from hyperimmunized eggs should target more than one patho-
gen to be effective. Based on the prevalence of pathogens described 
in literature, animals need at least protection during the first 14 d of 
their lives.
In addition, IgY is not the only compound described in eggs to 
have immune modulatory effects (Vega et al., 2012). Both the egg 
white and egg yolk contain various biologically active components as 
summarized by Mine and Kovacs-Nolan (2004). As the IEP treatment 
contained whole freeze-dried eggs including both the egg white and 
the egg yolks, more active components other than just IgY may have 
been present.
Scouring is often associated with malabsorption of nutrients 
from the diet (Holland, 1990). In the current study, the IEP group 
ate more concentrates and calf live weight was also increased to a 
similar extent. Possibly, the calves had less problems with malab-
sorption from the diet because IgY could improve gut integrity and 
function, thus have more nutrients better digested and absorbed, 
resulting in improved growth performance. The variation in body 
weight gain of calves can be explained for 49% by the starter intake 
(Kertz, Reutzel & Mahony, 1984). Another possible reason for the 
better performance could be related to a subclinical effect of IEP 
resulting in better health conditions of the animals. Providing egg 
proteins appears to prime the neonatal mucosal immune response 
(Vega et al., 2011) which may help the calf to deal with enteric dis-
eases early in life, and in this way could have the potential to im-
prove the growth for a longer period. No immune response markers 
were analysed in the current study to confirm any subclinical effects. 
Soberon et al. (2011) reported that each kilogram of additional ADG 
pre-weaning may result in a higher milk yield of at least 850 kg in 
the first lactation. This may be the result of a long lasting effect of 
higher starter intake, as exposure of calves to concentrates before 
weaning results in a higher concentrate intake post weaning (Xiao 
et al., 2018). Future studies in which the calves are followed until 
first lactation should be considered to investigate the impact of pre-
wean feed intake.
Interestingly, the calves in the IEP group drank more water than 
the calves in the PCB group. Kertz et al. (1984) showed that water 
intake was a result of scouring rather than a cause. This higher water 
intake suggests that the calves in the IEP group could deal better 
with the scouring.
The results of the current study indicate that feeding immunized 
egg proteins to calves in the first 14 days of life improves growth 
performance and concentrate intake. Although no significant health 
benefits were observed, further research should be done on possi-
ble subclinical health effects of immunized egg proteins.
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